![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (299)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (26)
Enyew Kindie, Melese Getachew, Abtie Abebaw, Wubetu Yihunie, Yalemgeta Biyazin, Bantayehu Addis Tegegne, Dehnnet Abebe, Tadesse Yirga Akalu & Aytenew Atnaf. (2023) Magnitude of anemia and associated factors among adult patients at Baso Liben District: a cross-sectional study. Expert Review of Hematology 16:1, pages 75-80.
Read now
Read now
Aschalew Kidanewold, Berhanu Woldu, Asmare Getie & Bamlaku Enawgaw. (2022) Anemia and its predictors among adult non-dialysis chronic kidney disease patients in Southern Ethiopia: a cross-sectional study. Current Medical Research and Opinion 38:3, pages 393-400.
Read now
Read now
Chuan-Ming Hao, Eric T Wittbrodt, Eirini Palaka, Nicolas Guzman, Alicia Dunn & Susan Grandy. (2021) Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China. International Journal of Nephrology and Renovascular Disease 14, pages 53-64.
Read now
Read now
Xenophon Kassianides, Adil Mohammad Hazara & Sunil Bhandari. (2021) Improving the safety of intravenous iron treatments for patients with chronic kidney disease. Expert Opinion on Drug Safety 20:1, pages 23-35.
Read now
Read now
Søren Viborg Vestergaard, Uffe Heide-Jørgensen, Heleen van Haalen, Glen James, Katarina Hedman, Henrik Birn, Reimar Wernich Thomsen & Christian Fynbo Christiansen. (2020) Risk of Anemia in Patients with Newly Identified Chronic Kidney Disease – A Population-Based Cohort Study. Clinical Epidemiology 12, pages 953-962.
Read now
Read now
Aishatu Mohammed Nalado, Johnny N Mahlangu, Bala Waziri, Raquel Duarte, Graham Paget, Gbenga Olorunfemi & Saraladevi Naicker. (2019) Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa. International Journal of Nephrology and Renovascular Disease 12, pages 19-32.
Read now
Read now
Akihito Tanaka, Daijo Inaguma, Yu Watanabe, Eri Ito, Naoki Kamegai, Hiroya Shimogushi, Hibiki Shinjo, Kiyomi Koike, Yasuhiro Otsuka & Asami Takeda. (2017) Ferrokinetics is associated with the left ventricular mass index in patients with chronic kidney disease. Acta Cardiologica 72:4, pages 460-466.
Read now
Read now
Mary Lynn Davis-Ajami, Jun Wu, Katherine Downton, Emilie Ludeman & Virginia Noxon. (2014) Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility. Biologics: Targets and Therapy 8, pages 155-167.
Read now
Read now
Turun Song, Li Wang, Shaofeng He, Lei Fu, Zhongli Huang, Qiang Wei & Tao Lin. (2014) The pre-transplant anemic condition is independent of long-term outcome in living-related kidney transplantation. Renal Failure 36:5, pages 673-677.
Read now
Read now
Lucia Del Vecchio & Francesco Locatelli. (2014) New treatment approaches in chronic kidney disease-associated anaemia. Expert Opinion on Biological Therapy 14:5, pages 687-696.
Read now
Read now
Massimo Morosetti, Antonio Gorini, Anna Maria Costanzo, Silvia Cipriani, Sara Dominijanni, Colin G Egan, Laura Zappalà & Umberto di Luzio Paparatti. (2013) Clinical management of nondialysis patients with chronic kidney disease: a retrospective observational study. Data from the SONDA study (Survey Of Non-Dialysis outpAtients). International Journal of Nephrology and Renovascular Disease 6, pages 27-37.
Read now
Read now
Paul D. Wilson, Adam Hutchings, Aruna Jeans & Iain C. Macdougall. (2013) An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. Journal of Medical Economics 16:1, pages 108-114.
Read now
Read now
Floortje E. van Nooten, Julia Green, Ruth Brown, Fredric O. Finkelstein & Jay Wish. (2010) Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature. Journal of Medical Economics 13:2, pages 241-256.
Read now
Read now
Ugo Testa. (2010) Erythropoietic stimulating agents. Expert Opinion on Emerging Drugs 15:1, pages 119-138.
Read now
Read now
Iain C. Macdougall. (2010) Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?. Current Medical Research and Opinion 26:2, pages 473-482.
Read now
Read now
Rebecca J Schmidt. (2009) Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off?. Expert Opinion on Pharmacotherapy 10:9, pages 1509-1514.
Read now
Read now
Amir Hayat, Dhiren Haria & Moro O Salifu. (2008) Erythropoietin stimulating agents in the management of anemia of chronic kidney disease. Patient Preference and Adherence 2, pages 195-200.
Read now
Read now
Naushira Pandya, Brahim Bookhart, Samir H. Mody, Paula A. Funk Orsini & Gregory Reardon. (2008) Study of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents. Current Medical Research and Opinion 24:8, pages 2139-2149.
Read now
Read now
Rafia S. Rasu, Tonya Crawford, Harold Manley & Rajesh Balkrishnan. (2008) Treatment and costs associated with anemic chronic kidney disease patients. Current Medical Research and Opinion 24:1, pages 129-137.
Read now
Read now
Francesco Locatelli & Bruno Reigner. (2007) C.E.R.A.: pharmacodynamics, pharmacokinetics and efficacy in patients with chronic kidney disease. Expert Opinion on Investigational Drugs 16:10, pages 1649-1661.
Read now
Read now
Jeffrey Hymes, Tammy Bickimer, James H. Jackson, Brahim K. Bookhart, Samir H. Mody & Catherine Tak Piech. (2007) Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa. Current Medical Research and Opinion 23:8, pages 1931-1937.
Read now
Read now
Frank J Papatheofanis. (2007) Comparative costs of treatment with epoetin alfa and darbepoetin alfa for anemia in the oncology and nephrology settings. Expert Review of Pharmacoeconomics & Outcomes Research 7:1, pages 59-73.
Read now
Read now
Jonathan T. C. Kwan & Raymond D. Pratt. (2007) Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients. Current Medical Research and Opinion 23:2, pages 307-311.
Read now
Read now
Beril Akman, Ayse Bilgic, Gulsah Sasak, Siren Sezer, Atilla Sezgin, Zubeyde Arat, F. Nurhan Ozdemir & Mehmet Haberal. (2007) Mortality Risk Factors in Chronic Renal Failure Patients after Coronary Artery Bypass Grafting. Renal Failure 29:7, pages 823-828.
Read now
Read now
Jeffrey Hoggard, Thomas Crouch, Stephen McMurray, Michael Levine, Radha Prathikanti, Debra Scarlata & Paul Audhya. (2006) Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis. Current Medical Research and Opinion 22:10, pages 2023-2030.
Read now
Read now
Frank J. Papatheofanis, R. Scott McKenzie, Samir H. Mody, Robert Y. Suruki & Catherine Tak Piech. (2006) Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia. Current Medical Research and Opinion 22:5, pages 837-842.
Read now
Read now
Articles from other publishers (273)
Oluseyi Ademola Adejumo, Imuetinyan Rashida Edeki, Manmak Mamven, Olawale Stephen Oguntola, Ogochukwu Chinedum Okoye, Akinwumi Ayodeji Akinbodewa, Enajite Ibiene Okaka, Sulaiman Dazumi Ahmed, Oghenekaro Gódwin Egbi, Joshua Falade, Samuel Ayokunle Dada, Monday Ogiagah Ogiator & Barbara Okoh. (2023) Sleep quality and associated factors among patients with chronic kidney disease in Nigeria: a cross-sectional study. BMJ Open 13:12, pages e074025.
Crossref
Crossref
Erika AraujoIan M. BellAlexander BurckleDennis C. KoesterJames R. ManningGeorgette Castanedo, Mingshuo Zeng, T. G. Murali DharNatalie Holmberg-Douglas, Eric R. Welin, J. Robert MerrittKevin M. PeeseJoanne J. Bronson. 2023. 2023 Medicinal Chemistry Reviews. 2023 Medicinal Chemistry Reviews
595
710
.
Michał Nowicki, Maciej Drożdż, Jarosław Wajda, Wiesław Klatko & Agnieszka Segiet-Święcicka. (2023) Continuous Erythropoietin Receptor Activator for the Treatment of Chronic Dialysis Patients with Renal Anemia in Daily Clinical Practice in Poland: A Non-Interventional, Multi-Center, Pragmatic NAVIGO Trial. Nephron, pages 1-1.
Crossref
Crossref
Isaac Nies, Emilee Gourde, William Newman & Renae Schiele. (2023) Impact of Iron Supplementation on Hospital Length of Stay for Pneumonia or Skin and Skin Structure Infections: A Retrospective Cohort Study. Hospital Pharmacy.
Crossref
Crossref
Emad Samaan, Mohammed Nagah & Ghada El Said. (2023) Phosphate kinetic modeling as an estimate of daily ingested phosphate in hemodialysis patients with or without residual kidney function. Therapeutic Apheresis and Dialysis.
Crossref
Crossref
Karim Dardim, Jérôme Fernandes, Arnaud Panes, Julien Beisel, Aurélie Schmidt, Josephine Wolfram, Lora Todorova, Laurence Dubel & Thierry Lobbedez. (2023) Incidence, prevalence, and treatment of anemia of non-dialysis-dependent chronic kidney disease: A retrospective database study in France. PLOS ONE 18:7, pages e0287859.
Crossref
Crossref
Wenjuan Song, Liuyan Zhao, Xuekun Li & Baolin Wu. (2023) Altered brain activity in patients with end‐stage renal disease: A meta‐analysis of resting‐state functional imaging. Brain and Behavior 13:7.
Crossref
Crossref
Rafia Mazhar, Bhagwan Das, Santosh Kumar, Muhammad Tassaduq Khan, Sapna Bai & Babeeta Hinduja. (2023) Prevalence of Anemia in End Stage Renal Disease Patients on Maintenance Hemodialysis. Pakistan Journal of Health Sciences, pages 130-133.
Crossref
Crossref
Pavan Kumar M. (2023) Clinico-pathological correlation study in chronic kidney disease patients undergoing hemodialysis. Indian Journal of Pathology and Oncology 10:2, pages 141-147.
Crossref
Crossref
Roberto Minutolo, Maria Elena Liberti, Vittorio Simeon, Ferdinando C Sasso, Silvio Borrelli, Luca De Nicola & Carlo Garofalo. (2023) Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials. Clinical Kidney Journal.
Crossref
Crossref
Justin D. Sprick, Jinhee Jeong, Jeann L. Sabino-Carvalho, Sabrina Li & Jeanie Park. (2023) Neurocirculatory regulation and adaptations to exercise in chronic kidney disease. American Journal of Physiology-Heart and Circulatory Physiology 324:6, pages H843-H855.
Crossref
Crossref
Mitku Mammo Taderegew, Alemayehu Wondie, Tamene Fetene Terefe, Tadesse Tsehay Tarekegn, Fisha Alebel GebreEyesus, Shegaw Tesfa Mengist, Baye Tsegaye Amlak, Mamo Solomon Emeria, Abebe Timerga & Betregiorgis Zegeye. (2023) Anemia and its predictors among chronic kidney disease patients in Sub-Saharan African countries: A systematic review and meta-analysis. PLOS ONE 18:2, pages e0280817.
Crossref
Crossref
Saliha Yildirim & Tolga Yildirim. 2023. Management of Chronic Kidney Disease. Management of Chronic Kidney Disease
215
237
.
Queeneth KaluNathaniel UsoroOtu EttaRoseline EshiemomohJoseph Enabulele. (2022) Prevalence of pre-operative anemia and its implication for patient blood management in a Nigerian Hospital. Calabar Journal of Health Sciences 6, pages 59-64.
Crossref
Crossref
Anxin WangXuewei XieXue TianS. Claiborne Johnston, Hao LiPhilip M. Bath, Yingting ZuoJing Jing, Jinxi LinYilong WangXingquan ZhaoZixiao LiYong Jiang, Liping Liu, Xia MengYongjun Wang. (2022)
Ticagrelor–Aspirin Versus Clopidogrel–Aspirin Among
CYP2C19
Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial
. Annals of Internal Medicine 175:11, pages 1534-1542.
Crossref
Crossref
Romana Ryšavá. (2022) New developments in anaemia treatment - erythropoietin versus prolyl hydroxylase inhibitors?. Vnitřní lékařství 68:7, pages 438-443.
Crossref
Crossref
Axel Hofmann, Aryeh Shander, Neil Blumberg, Jeffrey M. Hamdorf, James P. Isbister & Irwin Gross. (2022) Patient Blood Management: Improving Outcomes for Millions While Saving Billions. What Is Holding It Up?. Anesthesia & Analgesia 135:3, pages 511-523.
Crossref
Crossref
Ling FengTie-Long ChenJuan ZhangQian WangJie LiuXi-En GuiJean-Pierre RoutyQian Cao. (2022) Clinical Characteristics and Outcomes of Chronic Kidney Disease in People Living with HIV in a Resource-Limited Center of Central China. AIDS Research and Human Retroviruses 38:9, pages 726-734.
Crossref
Crossref
Tadao Akizawa, Keiko Tanaka-Amino, Tetsuro Otsuka & Yusuke Yamaguchi. (2022) Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat. Clinical and Experimental Nephrology 26:9, pages 843-850.
Crossref
Crossref
Hanako Kobayashi, Olena Davidoff, Shiuli Pujari‐Palmer, Malin Drevin & Volker H. Haase. (2022) EPO synthesis induced by HIF‐PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non‐injured nephron segments in murine kidney fibrosis. Acta Physiologica 235:4.
Crossref
Crossref
Cem Tanriover, Duygu Ucku, Carlo Basile, Katherine R. Tuttle & Mehmet Kanbay. (2022) On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease. Journal of Nephrology 35:9, pages 2191-2204.
Crossref
Crossref
Jovana Joksimovic Jovic, Svetlana Antic, Tomislav Nikolic, Kristina Andric, Dejan Petrovic, Sergey Bolevich & Vladimir Jakovljevic. (2022) Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress. Oxidative Medicine and Cellular Longevity 2022, pages 1-10.
Crossref
Crossref
Simit M. Doshi & Jay B. Wish. (2022) Past, Present, and Future of Phosphate Management. Kidney International Reports 7:4, pages 688-698.
Crossref
Crossref
Zhikai Yang, Tiantian Ma, Xiao Xu, Gang Fu, Jing Zhao, Ying Xu, Bin Yang, Di Song, Sainan Zhu, Jicheng Lv & Jie Dong. (2022) Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis. Kidney International Reports 7:3, pages 455-464.
Crossref
Crossref
B Waziri, BT Babawale & MO Mabayoje. (2022) Evaluation of iron status in anemic pre-dialysis chronic kidney disease patients. Nigerian Journal of Clinical Practice 25:3, pages 226.
Crossref
Crossref
Yan Shen, Jinwei Wang, Jing Yuan, Li Yang, Fangfang Yu, Xiaolei Wang, Ming-Hui Zhao, Luxia Zhang & Yan Zha. (2021) Anemia among Chinese patients with chronic kidney disease and its association with quality of life - results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrology 22:1.
Crossref
Crossref
Pablo E. Pergola & Nelson P. Kopyt. (2021) Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension. American Journal of Kidney Diseases 78:6, pages 846-856.e1.
Crossref
Crossref
Sheena Pramod & David S. Goldfarb. (2021) Challenging patient phenotypes in the management of anaemia of chronic kidney disease. International Journal of Clinical Practice 75:11.
Crossref
Crossref
André Bonadias Gadelha, Matteo Cesari, Hugo Luca Corrêa, Rodrigo Vanerson Passos Neves, Caio Victor Sousa, Lysleine Alves Deus, Michel Kendy Souza, Andrea Lucena Reis, Milton Rocha Moraes, Jonato Prestes, Herbert Gustavo Simões, Rosangela Vieira Andrade, Gislane Ferreira Melo & Thiago Santos Rosa. (2021) Effects of pre-dialysis resistance training on sarcopenia, inflammatory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial. International Urology and Nephrology 53:10, pages 2137-2147.
Crossref
Crossref
Isabelle Kitty Stanley, Kadin L Schultz, Kyle M Gardiner & Christine E Staatz. (2021) Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patients. Journal of Pharmaceutical Health Services Research 12:3, pages 350-356.
Crossref
Crossref
Giulio Giordano, Mariasanta Napolitano, Valeria Di Battista & Alessandro Lucchesi. (2020) Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study. Annals of Hematology 100:9, pages 2173-2179.
Crossref
Crossref
Leonid Livshits, Gregory Barshtein, Dan Arbell, Alexander Gural, Carina Levin & Hélène Guizouarn. (2021) Do We Store Packed Red Blood Cells under “Quasi-Diabetic” Conditions?. Biomolecules 11:7, pages 992.
Crossref
Crossref
Masaomi Nangaku, Kazuoki Kondo, Yoshimasa Kokado, Kiichiro Ueta, Genki Kaneko, Tsubasa Tandai, Yutaka Kawaguchi & Yasuhiro Komatsu. (2021) Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD. Journal of the American Society of Nephrology 32:7, pages 1779-1790.
Crossref
Crossref
Ji-Hye Kwon, Jungchan Park, Seung-Hwa Lee, Jong Hwan Lee, Jeong Jin Min, Jihoon Kim, Ah Ran Oh, Wonho Seo, Cheol Won Hyeon, Kwangmo Yang, Jin-ho Choi, Sang-Chol Lee, Kyunga Kim, Joonghyun Ahn & Hyeon-Cheol Gwon. (2021) Pre-operative anaemia and myocardial injury after noncardiac surgery. European Journal of Anaesthesiology 38:6, pages 582-590.
Crossref
Crossref
Dan Luo, Zhong Zhong, Yagui Qiu, Yating Wang, Hongyu Li, Jianxiong Lin, Wei Chen, Xiao Yang & Haiping Mao. (2021) Abnormal iron status is associated with an increased risk of mortality in patients on peritoneal dialysis. Nutrition, Metabolism and Cardiovascular Diseases 31:4, pages 1148-1155.
Crossref
Crossref
Victor da Silva, Hugo Corrêa, Rodrigo Neves, Lysleine Deus, Andrea Reis, Michel Souza, Cláudio dos Santos, Danilo de Castro, Fernando Honorato, Herbert Simões, Milton Moraes, Brad Schoenfeld, Jonato Prestes & Thiago Rosa. (2021) Impact of Low Hemoglobin on Body Composition, Strength, and Redox Status of Older Hemodialysis Patients Following Resistance Training. Frontiers in Physiology 12.
Crossref
Crossref
Steven Fishbane, Mohamed A. El-Shahawy, Roberto Pecoits-Filho, Bui Pham Van, Mark T. Houser, Lars Frison, Dustin J. Little, Nicolas J. Guzman & Pablo E. Pergola. (2021) Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study. Journal of the American Society of Nephrology 32:3, pages 737-755.
Crossref
Crossref
Kyle D. Maxwell, Justin Chuang, Muhammad Chaudhry, Ying Nie, Fang Bai, Komal Sodhi, Jiang Liu & Joseph I. Shapiro. (2021) The potential role of Na-K-ATPase and its signaling in the development of anemia in chronic kidney disease. American Journal of Physiology-Renal Physiology 320:2, pages F234-F242.
Crossref
Crossref
Nadezhda Viktorovna Kurkina, E.L. Gorshenina, L.V. Chegodaeva & A.V. Polagimova. (2021) Anemia of Chronic Diseases. Clinical oncohematology 14:3, pages 347-354.
Crossref
Crossref
Pao-Yen Lin, Lung-Chih Li, Liang-Jen Wang, Yao-Hsu Yang & Chih-Wei Hsu. (2021) Lack of association between erythropoietin treatment and risk of depression in patients with end-stage kidney disease on maintenance dialysis: a nationwide database study in Taiwan. Therapeutic Advances in Chronic Disease 12, pages 204062232199569.
Crossref
Crossref
Mohammad Habibur Rahman Sarker, Michiko Moriyama, Harun Ur Rashid, Mohammod Jobayer Chisti, Md Moshiur Rahman, Sumon Kumar Das, Aftab Uddin, Samir Kumar Saha, Shams El Arifeen, Tahmeed Ahmed & ASG Faruque. (2021) Community-based screening to determine the prevalence, health and nutritional status of patients with CKD in rural and peri-urban Bangladesh. Therapeutic Advances in Chronic Disease 12, pages 204062232110352.
Crossref
Crossref
Ahmed A Awan, Carl P Walther, Peter A Richardson, Maulin Shah, Wolfgang C Winkelmayer & Sankar D Navaneethan. (2021) Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrology Dialysis Transplantation 36:1, pages 129-136.
Crossref
Crossref
Ewa Wojtaszek, Tomasz Glogowski & Jolanta Malyszko. (2020) Iron and Chronic Kidney Disease: Still a Challenge. Frontiers in Medicine 7.
Crossref
Crossref
Esther C. W. de Boer, Anouk G. van Mourik & Ilse Jongerius. (2020) Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease. Frontiers in Immunology 11.
Crossref
Crossref
Philip A. Kalra, Sunil Bhandari, Michael Spyridon, Rachel Davison, Sarah Lawman, Ashraf Mikhail, David Reaich, Nick Pritchard, Kieran McCafferty & Jason Moore. (2020) NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease. BMC Nephrology 21:1.
Crossref
Crossref
Nhan Hieu Dinh, Suzanne Monivong Cheanh Beaupha & Loan Thi Anh Tran. (2020) The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening iron-deficiency anemia among patients with end-stage renal disease: a retrospective analysis. BMC Nephrology 21:1.
Crossref
Crossref
B. N. Harding, B. M. Whitney, R. M. Nance, S. A. Ruderman, H. M. Crane, G. Burkholder, R. D. Moore, W. C. Mathews, J. J. Eron, P. W. Hunt, P. Volberding, B. Rodriguez, K. H. Mayer, M. S. Saag, M. M. Kitahata, S. R. Heckbert & J. A. C. Delaney. (2020) Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study. BMC Infectious Diseases 20:1.
Crossref
Crossref
Fabrizio Papa, Valentino Miconi, Bruno Biasioli, Anna M. Cenci & Maria Golato. (2020) I biomarcatori di carenza marziale: nuove acquisizioni fisiopatologiche e necessità interpretative. La Rivista Italiana della Medicina di Laboratorio 16:3.
Crossref
Crossref
Esraa A. Ghazaly, Afaf M. EL-Saeed, Mostafa Abdelsalam & Dina M. Seoudi. (2020) Potential protective effect of leptin and uncoupling protein-2 genes polymorphism in Egyptian patients with chronic kidney disease. International Urology and Nephrology 52:11, pages 2153-2160.
Crossref
Crossref
Chao Yang, Qinqin Meng, Huaiyu Wang, Yafeng Wang, Zaiming Su, Lili Liu, Wenwen Liu, Guilan Kong, Luxia Zhang, Yaohui Zhao & Ming-Hui Zhao. (2020) Anemia and Kidney Function Decline among the Middle-Aged and Elderly in China: A Population-Based National Longitudinal Study. BioMed Research International 2020, pages 1-7.
Crossref
Crossref
Sting Ray Gouveia Moura, Hugo Luca Corrêa, Rodrigo Vanerson Passos Neves, Cláudio Avelino Rodrigues Santos, Luiz Sinésio Silva Neto, Victor Lopes Silva, Michel Kendy Souza, Lysleine Alves Deus, Andrea Lucena Reis, Herbert Gustavo Simões, Fabiani Lage Rodrigues Beal, Milton Rocha Moraes, James W. Navalta, Jonato Prestes, André Bonadias Gadelha & Thiago dos Santos Rosa. (2020) Effects of resistance training on hepcidin levels and iron bioavailability in older individuals with end-stage renal disease: A randomized controlled trial. Experimental Gerontology 139, pages 111017.
Crossref
Crossref
Eya Hamza, Laurent Metzinger & Valérie Metzinger-Le Meuth. (2020) Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review. Cells 9:9, pages 2039.
Crossref
Crossref
J. Rössler, I. Hegemann, F. Schoenrath, B. Seifert, A. Kaserer, G. H. Spahn, V. Falk & D. R. Spahn. (2020) Efficacy of quadruple treatment on different types of pre‐operative anaemia: secondary analysis of a randomised controlled trial. Anaesthesia 75:8, pages 1039-1049.
Crossref
Crossref
Michelle M Y Wong, Charlotte Tu, Yun Li, Rachel L Perlman, Roberto Pecoits-Filho, Antonio A Lopes, Ichiei Narita, Helmut Reichel, Friedrich K Port, Nidhi Sukul, Benedicte Stengel, Bruce M Robinson, Ziad A Massy, Ronald L Pisoni, Christian Combe, Christian Jacquelinet, Carole Ayav, Serge Briançon, Denis Fouque, Luc Frimat, Maurice Laville, Christophe Pascal, Yves-Edouard Herpe, Céline Lange, Karine Legrans, Sophie Liabeuf, Marie Metzger, Elodie Speyer, Christian Combe, Christian Jacquelinet, Carole Ayav, Serge Briançon, Denis Fouque, Luc Frimat, Maurice Laville, Christophe Pascal, Yves-Edouard Herpe, Céline Lange, Karine Legrans, Sophie Liabeuf, Marie Metzger & Elodie Speyer. (2020) Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated. Clinical Kidney Journal 13:4, pages 613-624.
Crossref
Crossref
Eirini Palaka, Susan Grandy, Heleen van Haalen, Phil McEwan & Oliver Darlington. (2020) The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review. International Journal of Nephrology 2020, pages 1-21.
Crossref
Crossref
Steven Fishbane & Daniel W Coyne. (2020) How we treat Renal Anemia. Blood.
Crossref
Crossref
Selma Alagoz, Mevlut Tamer Dincer, Necmi Eren, Alev Bakir, Meltem Pekpak, Sinan Trabulus & Nurhan Seyahi. (2020) Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?. PLOS ONE 15:4, pages e0230980.
Crossref
Crossref
Eun‐Hee Nah, Seon Cho, Suyoung Kim, Jieun Chu, Eunjoo Kwon & Han‐Ik Cho. (2020) Distribution of hemoglobin levels and prevalence of anemia according to sex, age group, and region in 13 Korean cities. International Journal of Laboratory Hematology 42:2, pages 223-229.
Crossref
Crossref
Pascal Chanu, Franz Schaefer, Bradley A. Warady, Claus Peter Schmitt, Bruno Reigner, Gabriel Schnetzler, Sylvie Meyer Reigner, Mark Eisner, Arlette Weichert & Nicolas Frey. (2020) Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. British Journal of Clinical Pharmacology 86:4, pages 801-811.
Crossref
Crossref
Ly Minh Nguyen, Calvin J. Meaney, Gauri G. Rao, Mandip Panesar & Wojciech Krzyzanski. (2020) Application of Reticulocyte-Based Estimation of Red Blood Cell Lifespan in Anemia Management of End-Stage Renal Disease Patients. The AAPS Journal 22:2.
Crossref
Crossref
M. D. Cappellini, K. M. Musallam & A. T. Taher. (2019) Iron deficiency anaemia revisited. Journal of Internal Medicine 287:2, pages 153-170.
Crossref
Crossref
Phillip Staibano, Iris Perelman, Julia Lombardi, Alexandra Davis, Alan Tinmouth, Marc Carrier, Ciara Stevenson & Elianna Saidenberg. (2020) Patient-Centred Outcomes in Anaemia and Renal Disease: A Systematic Review. Kidney Diseases 6:2, pages 74-84.
Crossref
Crossref
Bernhard Scheiner, Georg Semmler, Florian Maurer, Philipp Schwabl, Theresa A. Bucsics, Rafael Paternostro, David Bauer, Benedikt Simbrunner, Michael Trauner, Mattias Mandorfer & Thomas Reiberger. (2019) Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver International 40:1, pages 194-204.
Crossref
Crossref
Satinderjit Locham, Asma Mathlouthi, Hanaa Dakour-Aridi, Besma Nejim & Mahmoud B. Malas. (2020) Association between Severe Anemia and Outcomes of Hemodialysis Vascular Access. Annals of Vascular Surgery 62, pages 295-303.
Crossref
Crossref
Blaise Abramovitz & Jeffrey S. Berns. 2020. Chronic Renal Disease. Chronic Renal Disease
991
1000
.
Shiv Kumar Sah & Laxman Prasad Adhikary. (2019) Prevalence of abnormal serum 25-hydroxyvitamin D and its association with hemoglobin level in pre dialysis CKD patients: a cross-sectional study from Himalayan country. BMC Nephrology 20:1.
Crossref
Crossref
Salman Hussain, Anwar Habib & Abul Kalam Najmi. (2019) Anemia prevalence and its impact on health‐related quality of life in Indian diabetic kidney disease patients: Evidence from a cross‐sectional study. Journal of Evidence-Based Medicine 12:4, pages 243-252.
Crossref
Crossref
Kuo-Chuan Hung, Chun-Ning Ho, Jen-Yin Chen, Wei-Cheng Liu, Cheuk-Kwan Sun & Tien-Chou Soong. (2019) Association of preoperative hemoglobin with weight loss after bariatric surgery: a retrospective study. Surgery for Obesity and Related Diseases 15:9, pages 1595-1603.
Crossref
Crossref
Franco Musio. (2019) Kidney Disease and Anemia in Elderly Patients. Clinics in Geriatric Medicine 35:3, pages 327-337.
Crossref
Crossref
Ujjala Kumar, Nicholas Wettersten & Pranav S. Garimella. (2019) Cardiorenal Syndrome. Cardiology Clinics 37:3, pages 251-265.
Crossref
Crossref
Ting Lu, Wen-e Zhao, Fang Zhang, Xiaohong Qi, Ye Yang & Chunyan Gu. (2019) Lycium barbarum polysaccharides attenuate rat anti-Thy-1 glomerulonephritis through mediating pyruvate dehydrogenase. Biomedicine & Pharmacotherapy 116, pages 109020.
Crossref
Crossref
Amit X. Garg, Neal Badner, Sean M. Bagshaw, Meaghan S. Cuerden, Dean A. Fergusson, Alexander J. Gregory, Judith Hall, Gregory M. T. Hare, Boris Khanykin, Shay McGuinness, Chirag R. Parikh, Pavel S. Roshanov, Nadine Shehata, Jessica M. Sontrop, Summer Syed, George I. Tagarakis, Kevin E. Thorpe, Subodh Verma, Ron Wald, Richard P. Whitlock & C. David Mazer. (2019) Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial. Journal of the American Society of Nephrology 30:7, pages 1294-1304.
Crossref
Crossref
Pablo E. Pergola, Steven Fishbane & Tomas Ganz. (2019) Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease. Advances in Chronic Kidney Disease 26:4, pages 272-291.
Crossref
Crossref
Adel Abdel-Moneim, Basant Mahmoud, Ahmad Nabil & Zinab Negeem. (2019) Correlation between oxidative stress and hematological profile abnormalities in diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:4, pages 2365-2373.
Crossref
Crossref
Yun-Gyoo Lee, Yoosoo Chang, Jihoon Kang, Dong-Hoe Koo, Seung-Sei Lee, Seungho Ryu & Sukjoong Oh. (2019) Risk factors for incident anemia of chronic diseases: A cohort study. PLOS ONE 14:5, pages e0216062.
Crossref
Crossref
Steven Fishbane, Daniel W. Ross & Susana Hong. (2019) Anemia in Non–Dialysis-Dependent CKD: To Treat or Not to Treat?. American Journal of Kidney Diseases 73:3, pages 297-299.
Crossref
Crossref
Saroj Kunwar, Bimal Chaulagain, Rajendra KC, Pradeep Pokhrel & Apeksha Niraula. (2019) Hyperuricemia, anemia and chronic kidney disease: a conundrum in the shadow. International Journal of Medicine in Developing Countries, pages 648-653.
Crossref
Crossref
Julia Brodski, Susan L. Rossell, David J. Castle & Eric J. Tan. (2018) A Systematic Review of Cognitive Impairments Associated With Kidney Failure in Adults Before Natural Age-Related Changes. Journal of the International Neuropsychological Society 25:1, pages 101-114.
Crossref
Crossref
Jeffrey S. Berns, Tiffany C. Wong & Solomon Dawson. 2019. Chronic Kidney Disease, Dialysis, and Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation
136
144.e6
.
Nidhi Gupta, Shiwani Aggarwal & Vasudha Singhal. 2019. Co-existing Diseases and Neuroanesthesia. Co-existing Diseases and Neuroanesthesia
107
154
.
Mayra Vera-Aviles, Eleni Vantana, Emmy Kardinasari, Ngat Koh & Gladys Latunde-Dada. (2018) Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease. Pharmaceuticals 11:4, pages 111.
Crossref
Crossref
V. M. Ibragimov, A. M. Aliskandiev & I. V. Sarvilina. (2018) ABOUT THE ROLE OF THE PODOCIN PROTEIN IN DYSFUNCTION OF KIDNEYS IN PATIENTS WITH DIABETES MELLITUS TYPE 2. Nephrology (Saint-Petersburg) 22:5, pages 31-38.
Crossref
Crossref
А.В. Будневский, Е.С. Овсянников, Е.В. Воронина, Н.Б. Лабжания & Ю.Г. Жусина. (2018) Новые подходы к лечению анемии хронических заболеваний. ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»:3(), pages 106-112.
Crossref
Crossref
Romana Ryšavá. (2018) Novel treatment options for anaemia in patients with chronic kidney disease. Klinická farmakologie a farmacie 32:1, pages 8-13.
Crossref
Crossref
Austin G Stack, Ahmed Alghali, Xia Li, John P Ferguson, Liam F Casserly, Cornelius J Cronin, Donal N Reddan, Wael Hussein & Mohamed E Elsayed. (2018) Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study. Clinical Kidney Journal 11:1, pages 99-107.
Crossref
Crossref
Carola-Ellen Kleine, Melissa Soohoo, Omesh N. Ranasinghe, Christina Park, Maria V. Marroquin, Yoshitsugu Obi, Connie M. Rhee, Hamid Moradi, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh & Elani Streja. (2018) Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes. American Journal of Nephrology 47:5, pages 333-342.
Crossref
Crossref
Axel Dignass, Karima Farrag & Jürgen Stein. (2018) Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. International Journal of Chronic Diseases 2018, pages 1-11.
Crossref
Crossref
Pyry P. Jämsä, Niku K.J. Oksala, Antti P. Eskelinen & Esa R. Jämsen. (2018) Chronic Kidney Diseases Among Patients Undergoing Elective Arthroplasty: Risk Groups and the Value of Serum Creatinine. The Journal of Arthroplasty 33:1, pages 230-234.e1.
Crossref
Crossref
Mark A. Crowther & Ali Iqbal. 2018. Hematology. Hematology
2244
2246
.
Lynda Szczech. 2018. Management of Anemia. Management of Anemia
1
10
.
Tetsuya Kawamura, Joichi Usui, Shuzo Kaneko, Ryoya Tsunoda, Eri Imai, Hirayasu Kai, Naoki Morito, Chie Saito, Michio Nagata & Kunihiro Yamagata. (2017) Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study. BMC Nephrology 18:1.
Crossref
Crossref
Elizabeth Helene Louw & Mogamat-Yazied Chothia. (2017) Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study. BMC Nephrology 18:1.
Crossref
Crossref
Hirotsugu Kanda, Yuji Hirasaki, Takafumi Iida, Megumi Kanao-Kanda, Yuki Toyama, Takashi Chiba & Takayuki Kunisawa. (2017) Perioperative Management of Patients With End-Stage Renal Disease. Journal of Cardiothoracic and Vascular Anesthesia 31:6, pages 2251-2267.
Crossref
Crossref
Daniel W. Coyne, David Goldsmith & Iain C. Macdougall. (2017) New options for the anemia of chronic kidney disease. Kidney International Supplements 7:3, pages 157-163.
Crossref
Crossref
Kazuhiko Tsuruya, Yukari Uemura, Hideki Hirakata, Takanari Kitazono, Yoshiharu Tsubakihara, Masashi Suzuki & Yasuo Ohashi. (2017) Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials. Nephrology 22:10, pages 769-775.
Crossref
Crossref
Maria Domenica Cappellini, Josep Comin‐Colet, Angel de Francisco, Axel Dignass, Wolfram Doehner, Carolyn S. Lam, Iain C. Macdougall, Gerhard Rogler, Clara Camaschella, Rezan Kadir, Nicholas J. Kassebaum, Donat R. Spahn, Ali T. Taher & Khaled M. Musallam. (2017) Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. American Journal of Hematology 92:10, pages 1068-1078.
Crossref
Crossref
Mohammed Umar Farooque & Bharat Bhushan. (2017) ANAEMIA AND CHRONIC KIDNEY DISEASE. Journal of Evidence Based Medicine and Healthcare 4:39, pages 2352-2354.
Crossref
Crossref
Guus A. M. Kortman, Dorien Reijnders & Dorine W. Swinkels. (2017) Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD. Hemodialysis International 21:S1.
Crossref
Crossref
Vincenzo Bellizzi, Giuseppe Conte, Silvio Borrelli, Adamasco Cupisti, Luca De Nicola, Biagio R. Di Iorio, Gianfranca Cabiddu, Marcora Mandreoli, Ernesto Paoletti, Giorgina B. Piccoli, Giuseppe Quintaliani, Maura Ravera, Domenico Santoro, Serena Torraca & Roberto Minutolo. (2016) Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology. Journal of Nephrology 30:2, pages 159-170.
Crossref
Crossref
J. B. Ernst, A. Zittermann, S. Pilz, M. E. Kleber, H. Scharnagl, V. M. Brandenburg, W. König, T. B. Grammer & W. März. (2016) Independent associations of vitamin D metabolites with anemia in patients referred to coronary angiography: the LURIC study. European Journal of Nutrition 56:3, pages 1017-1024.
Crossref
Crossref
Carmen Denise Căldăraru, Dorin Ionuţ Tarta, Mirela Liana Gliga, Cristina Tarta, Emilian Caraşca, Sorin Albu, Adina Huţanu, Maria Dogaru & Grigore Dogaru. (2017) Research Article. Comparative Analysis of Hepcidin-25 and Inflammatory Markers in Patients with Chronic Kidney Disease with and without Anemia. Acta Medica Marisiensis 63:1, pages 10-14.
Crossref
Crossref
John G Kingma, Denys Simard & Jacques R Rouleau. (2017) Influence of cardiac nerve status on cardiovascular regulation and cardioprotection. World Journal of Cardiology 9:6, pages 508.
Crossref
Crossref
Mirsad Panjeta, Ismet Tahirovi?Emin Sofi?Jozo ?ori?Amela Dervi?evi?. (2017) Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease. Journal of Medical Biochemistry 36:2.
Crossref
Crossref
Shahriar Dadkhah & Korosh Sharain. 2017. Short Stay Management of Acute Heart Failure. Short Stay Management of Acute Heart Failure
295
307
.
Samuel Antwi-Bafour, Samuel Hammond, Jonathan Kofi Adjei, Ransford Kyeremeh, Alexander Martin-Odoom & Ivy Ekem. (2016) A case–control study of prevalence of anemia among patients with type 2 diabetes. Journal of Medical Case Reports 10:1.
Crossref
Crossref
Hwee-Lin Wee, Benjamin Jun Jie Seng, Jia Jia Lee, Kok Joon Chong, Pallavi Tyagi, Anantharaman Vathsala & Priscilla How. (2016) Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients. Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
Chi Huu Hong Le. (2016) The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012). PLOS ONE 11:11, pages e0166635.
Crossref
Crossref
Ya Li, Hao Shi, Wei-Ming Wang, Ai Peng, Geng-Ru Jiang, Jin-Yuan Zhang, Zhao-Hui Ni, Li-Qun He, Jian-Ying Niu, Nian-Song Wang, Chang-Lin Mei, Xu-Dong Xu, Zhi-Yong Guo, Wei-Jie Yuan, Hai-Dong Yan, Yue-Yi Deng, Chen Yu, Jun Cen, Yun Zhang & Nan Chen. (2016) Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease. Medicine 95:24, pages e3872.
Crossref
Crossref
Samar K.M. Khalil, H.A. Amer, Adel M. El Behairy & Mohamad Warda. (2016) Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies. Journal of Advanced Research 7:3, pages 348-358.
Crossref
Crossref
Ferdane Sapmaz, Sebahat Başyiğit, İsmail Hakkı Kalkan, Üçler Kısa, Engin Eren Kavak & Sefa Güliter. (2016) The impact of Helicobacter pylori eradication on serum hepcidin-25 level and iron parameters in patients with iron deficiency anemia. Wiener klinische Wochenschrift 128:9-10, pages 335-340.
Crossref
Crossref
Muhammet Fatih KilincOmer Gokhan DoluogluTolga KarakanYildiray YildizNurettin Cem SonmezAyhan Dalkilic. (2016) Evaluation of Results of Diagnostic Ureteroscopy in Chronic Hemodialysis Patients. Journal of Endourology 30:4, pages 371-374.
Crossref
Crossref
Hwa Sun Lee & Sun Yung Ly. (2016) Nutrient intake status and relevant factors of hemodialysis patients hospitalized in general hospital located in Daejeon. Korean Journal of Human Ecology 25:1, pages 55.
Crossref
Crossref
Andreas Lammerich, Peter Balcke, Peter Bias, Simone Mangold & Martin Wiesholzer. (2016) Cardiovascular Morbidity and Pure Red Cell Aplasia Associated With Epoetin Theta Therapy in Patients With Chronic Kidney Disease: A Prospective, Noninterventional, Multicenter Cohort Study. Clinical Therapeutics 38:2, pages 276-287.e4.
Crossref
Crossref
J Rottembourg. (2016) Use of Iron Therapy in Chronic Kidney Disease. Archives of Clinical Nephrology, pages 001-003.
Crossref
Crossref
Charalampos Loutradis, Alexandra Skodra, Panagiotis Georgianos, Panagiota Tolika, Dimitris Alexandrou, Afroditi Avdelidou & Pantelis A Sarafidis. (2016) Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. World Journal of Nephrology 5:4, pages 358.
Crossref
Crossref
Peter Pyrko & Javad Parvizi. (2016) Renal and Gastrointestinal Considerations in Patients Undergoing Elective Orthopaedic Surgery. Journal of the American Academy of Orthopaedic Surgeons 24:1, pages e1-e8.
Crossref
Crossref
Sarita Bajaj, BrijMohan Makkar, VinodK Abichandani, PradeepG Talwalkar, Banshi Saboo, SS Srikanta, Ashok Das, Sruti Chandrasekaran, PVenkata Krishnan, Arun Shah, Georgi Abraham, Pankaj Tikku & Sushil Kumar. (2016) Management of anemia in patients with diabetic kidney disease: A consensus statement. Indian Journal of Endocrinology and Metabolism 20:2, pages 268.
Crossref
Crossref
Gregory E. Tong, Sant Kumar, Karen C. Chong, Nikita Shah, Margaret J. Wong, Jeffrey M. Zimmet, Zhen Jane Wang, Judy Yee, Yanjun Fu & Benjamin M. Yeh. (2015) Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration. Abdominal Radiology 41:1, pages 91-99.
Crossref
Crossref
Fenna van Breda & Marc G. Vervloet. 2016. Vitamin D in Chronic Kidney Disease. Vitamin D in Chronic Kidney Disease
391
404
.
Frank Ward, John Holian & Patrick T Murray. (2015) Drug therapies to delay the progression of chronic kidney disease. Clinical Medicine 15:6, pages 550-557.
Crossref
Crossref
Krasimira Atanassova, Jelka Masin-SpasovskaGoce SpasovskiEmil Paskalev. (2015) Is there any Gender Difference in the Association between Obesity, Chronic Kidney Disease and Anemia. BANTAO Journal 13:2, pages 79-83.
Crossref
Crossref
Bing Chang Vincent Lau, Kheng Yong Ong, Chun Wei Yap, Anantharaman Vathsala & Priscilla How. (2015) Predictors of anemia in a multi-ethnic chronic kidney disease population: a case–control study. SpringerPlus 4:1.
Crossref
Crossref
Teresa K. Chen, Michelle M. Estrella, Brad C. Astor, Tom Greene, Xuelei Wang, Morgan E. Grams & Lawrence J. Appel. (2015) Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK). Nephrology Dialysis Transplantation 30:8, pages 1329-1335.
Crossref
Crossref
Katherine Garlo, Deanna Williams, Lee Lucas, Rocket Wong, Joel Botler, Stuart Abramson & Mark G. Parker. (2015) Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease. Medicine 94:25, pages e964.
Crossref
Crossref
Jorge Eduardo Toblli & Federico Di Gennaro. (2015) Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status. PLOS ONE 10:4, pages e0125528.
Crossref
Crossref
Katharina Hellhammer, Jan Balzer, Tobias Zeus, Christos Rammos, Svenja Niebel, Laura Kubatz, Rabea Wagstaff, Malte Kelm & Tienush Rassaf. (2015) Percutaneous mitral valve repair using the MitraClip® system in patients with anemia. International Journal of Cardiology 184, pages 399-404.
Crossref
Crossref
Anthony C. Chyou, Anay Thodge, Dmitriy N. Feldman & Rajesh V. Swaminathan. (2015) Statins in the Prevention of Contrast-Induced Nephropathy. Current Treatment Options in Cardiovascular Medicine 17:4.
Crossref
Crossref
Laura Lorente-Fernández, Emilio Monte-Boquet, Isabel Gil-Gómez, Amparo Soldevila-Orient & José Luís Poveda-Andrés. (2015) Cost-effectiveness of methoxy polyethylene glycol-epoetin β versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice. European Journal of Hospital Pharmacy 22:2, pages 73-78.
Crossref
Crossref
Madhukar Gaikwad, Shyamal Sinha, Rashmi Sinha, Anitha Gore, Bhattacharjee S, Anjaiah T, Abdul Hannan & Kunal Patankar. (2015) CORRECTION OF ANAEMIA WITH ERYTHROPOIETIN IN CKD/ESRD PATIENTS. Journal of Evolution of Medical and Dental Sciences 04:12, pages 1927-1935.
Crossref
Crossref
Hyang Mo Koo, Fa Mee Doh, Chan Ho Kim, Mi Jung Lee, Eun Jin Kim, Jae Hyun Han, Ji Suk Han, Dong-Ryeol Ryu, Hyung Jung Oh, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo & Shin-Wook Kang. (2015) Changes in Echocardiographic Parameters According to the Rate of Residual Renal Function Decline in Incident Peritoneal Dialysis Patients. Medicine 94:7, pages e427.
Crossref
Crossref
Itir Yegenaga & Zeki Aydin. (2015) Low Serum Zinc Level May be Related to Higher Doses of EPO in Hemodialysis Patients. BANTAO Journal 12:1.
Crossref
Crossref
Kazuhiko Tsuruya, Masahiro Eriguchi, Shunsuke Yamada, Hideki Hirakata & Takanari Kitazono. (2015) Cardiorenal Syndrome in End-Stage Kidney Disease. Blood Purification 40:4, pages 337-343.
Crossref
Crossref
Omar Maoujoud, Samir Ahid, Hocein Dkhissi, Zouhair Oualim & Yahia Cherrah. (2015) The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients. Anemia 2015, pages 1-9.
Crossref
Crossref
Fadwa Saqr Al-Ali, Mohamed El-Sayed Abdelfattah, Ashraf Ahmed Fawzy, Ahmed Farouk Hamdy & Aisha Elsayed Abdulla. (2015) Erythropoietin-stimulating agents in the management of anemia of end-stage renal disease patients on regular hemodialysis: A prospective randomized comparative study from Qatar. Hemodialysis International 19:1, pages 33-43.
Crossref
Crossref
B. Clevenger & T. Richards. (2014) Pre‐operative anaemia. Anaesthesia 70:s1, pages 20.
Crossref
Crossref
David W. Johnson, Elaine M. Pascoe, Sunil V. Badve, Kim Dalziel, Alan Cass, Philip Clarke, Paolo Ferrari, Stephen P. McDonald, Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara & Carmel M. Hawley. (2015) A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial. American Journal of Kidney Diseases 65:1, pages 49-57.
Crossref
Crossref
Hilda Fernandez & Ajay K. Singh. 2015. Chronic Renal Disease. Chronic Renal Disease
624
633
.
Lodovico Balducci. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People
35
48
.
Noor Alsalimy & Ahmed Awaisu. (2014) Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review. International Journal of Clinical Pharmacy 36:6, pages 1115-1125.
Crossref
Crossref
Hyunwook Kim, Kyoung Hoon Kim, Kisoo Park, Shin-Wook Kang, Tae-Hyun Yoo, Song Vogue Ahn, Hyeong Sik Ahn, Hoo Jae Hann, Shina Lee, Jung-Hwa Ryu, Seung-Jung Kim, Duk-Hee Kang, Kyu Bok Choi & Dong-Ryeol Ryu. (2014) A population-based approach indicates an overall higher patient mortality with peritoneal dialysis compared to hemodialysis in Korea. Kidney International 86:5, pages 991-1000.
Crossref
Crossref
Qianchun Yang, Minawaer Abudou, Xi Sheng Xie & Taixiang Wu. (2014) Androgens for the anaemia of chronic kidney disease in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Yoshiyuki Morishita, Akihiko Numata, Atushi Miki, Mari Okada, Kenichi Ishibashi, Fumi Takemoto, Yasuhiro Ando, Shigeaki Muto & Eiji Kusano. (2013) Medication-prescribing patterns of primary care physicians in chronic kidney disease. Clinical and Experimental Nephrology 18:5, pages 690-696.
Crossref
Crossref
Andrea Cavalli & Giuseppe Pontoriero. (2018) What's the Latest on Iron Therapy?. Giornale di Tecniche Nefrologiche e Dialitiche 26:3, pages 296-300.
Crossref
Crossref
David William Mudge & David Wayne Johnson. (2014) Oral iron therapies in development for iron deficiency in chronic kidney disease. Clinical Investigation 4:7, pages 641-648.
Crossref
Crossref
Iain C. Macdougall, Andreas Bock, Fernando Carrera, Kai-Uwe Eckardt, Carlo Gaillard, David Van Wyck, Bernard Roubert, Timothy Cushway & Simon D. Roger. (2014) The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. Nephrology Dialysis Transplantation 29:4, pages 843-850.
Crossref
Crossref
Hyang Mo Koo, Chan Ho Kim, Fa Mee Doh, Mi Jung Lee, Eun Jin Kim, Jae Hyun Han, Ji Suk Han, Hyung Jung Oh, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo & Shin-Wook Kang. (2014) The Relationship of Initial Transferrin Saturation to Cardiovascular Parameters and Outcomes in Patients Initiating Dialysis. PLoS ONE 9:2, pages e87231.
Crossref
Crossref
Daniel E. Forman & Richert E. Goyette. (2013) Oral Anticoagulation Therapy for Elderly Patients With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis 20:1, pages 5-15.
Crossref
Crossref
R. Schneckenpointner, R. A. Jörres, N. Meidenbauer, F. Kollert, M. Pfeifer & S. Budweiser. (2014) The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure. International Journal of Clinical Practice 68:1, pages 130-138.
Crossref
Crossref
Yaling Han, Guoying Zhu, Lixian Han, Fengxia Hou, Weijian Huang, Huiliang Liu, Jihong Gan, Tiemin Jiang, Xiaoyan Li, Wei Wang, Shifang Ding, Shaobin Jia, Weifeng Shen, Dongmei Wang, Ling Sun, Jian Qiu, Xiaozeng Wang, Yi Li, Jie Deng, Jing Li, Kai Xu, Bo Xu, Roxana Mehran & Yong Huo. (2014) Short-Term Rosuvastatin Therapy for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease. Journal of the American College of Cardiology 63:1, pages 62-70.
Crossref
Crossref
José Portolés, Jose Luis Gorriz, Esther Rubio, Fernando de Alvaro, Florencio García, Vicente Alvarez-Chivas, Pedro Aranda & Alberto Martinez-Castelao. (2013) The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrology 14:1.
Crossref
Crossref
Roberto Minutolo, Francesco Locatelli, Maurizio Gallieni, Renzo Bonofiglio, Giorgio Fuiano, Lamberto Oldrizzi, Giuseppe Conte, Luca De Nicola, Filippo Mangione, Pasquale Esposito & Antonio Dal Canton. (2013) Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. Nephrology Dialysis Transplantation 28:12, pages 3035-3045.
Crossref
Crossref
Jacques Rottembourg, Yves Sonigo, Aurélie Dansaert, Mirela Diaconita & Alain Guerin. (2013) La prise en charge de l’anémie et de ses conséquences chez les patients débutant l’hémodialyse : importance du fer intraveineux en prédialyse. Néphrologie & Thérapeutique 9:7, pages 486-493.
Crossref
Crossref
Youn Mi SongHye Eun YoonYoo A. ChoiEun Oh KimSang Ju LeeYoon Kyung ChangSuk Young KimChul Woo YangHyeon Seok Hwang. (2023) Use of Blood Tests to Predict Upper Gastrointestinal Lesions in Patients with Chronic Kidney Disease. Journal of Investigative Medicine 61:7, pages 1115-1120.
Crossref
Crossref
Michael Koch, Wolfgang Treiber & Danilo Fliser. (2013) Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study. Clinical Drug Investigation 33:10, pages 699-706.
Crossref
Crossref
Judith Partridge, Danielle Harari, Jessica Gossage & Jugdeep Dhesi. (2013) Anaemia in the older surgical patient: a review of prevalence, causes, implications and management. Journal of the Royal Society of Medicine 106:7, pages 269-277.
Crossref
Crossref
María Dolores Albero Molina, Ramón López-Menchero Martínez, Carlos del Pozo Fernández, Luis Álvarez Fernández & Laura Sánchez Rodríguez. (2013) Eficiencia de la administración mensual subcutánea de metoxi-polietilenglicol epoetina β (Mircera®) en pacientes estables en hemodiálisis previamente tratados con eritropoyetinaEficiencia de la administración sc mensual de MIRCERA en pacientes en HD. Diálisis y Trasplante 34:3, pages 93-100.
Crossref
Crossref
Karminder S. Gill, Paul Muntner, Richard A. Lafayette, Jeffrey Petersen, Jeffrey C. Fink, David T. Gilbertson & Brian D. Bradbury. (2013) Red blood cell transfusion use in patients with chronic kidney disease. Nephrology Dialysis Transplantation 28:6, pages 1504-1515.
Crossref
Crossref
Amir Sharafkhaneh, Suryakanta Velamuri, Jose Melendez, Farah Akhtar & Max Hirshkowitz. (2013) Medical Management of Fatigue. Sleep Medicine Clinics 8:2, pages 265-276.
Crossref
Crossref
Hashir Majid, Munira Shabbir-Moosajee & Sarah Nadeem. (2013) Fatigue in Other Medical Disorders. Sleep Medicine Clinics 8:2, pages 241-253.
Crossref
Crossref
Dagmara Hering, Murray D. Esler & Markus P. Schlaich. (2013) Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation. EuroIntervention 9:R, pages R127-R135.
Crossref
Crossref
David W Johnson, Emelia Atai, Maria Chan, Richard KS Phoon, Clodagh Scott, Nigel D Toussaint, Graeme L Turner, Tim Usherwood & Kathryn J Wiggins. (2013) KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management. Nephrology 18:5, pages 340-350.
Crossref
Crossref
Marino A. BruceBettina M. Beech, Errol D. CrookMario SimsDerek M. Griffith, Sean L. Simpson, Jamy Ard & Keith C. Norris. (2023) Sex, Weight Status, and Chronic Kidney Disease among African Americans: The Jackson Heart Study. Journal of Investigative Medicine 61:4, pages 701-707.
Crossref
Crossref
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas & George K Bertsias. (2013) An update on the management of comorbid conditions in lupus nephritis. Clinical Investigation 3:3, pages 281-293.
Crossref
Crossref
Kathleen M Fox, Jerry Yee, Ze Cong, John M Brooks, Jeffrey Petersen, Lois Lamerato & Shravanthi R Gandra. (2012) Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study. BMC Nephrology 13:1.
Crossref
Crossref
Chester H. Fox, Linda S. Kahn & Joseph Vassalotti. (2012) A Decade After the KDOQI CKD Guidelines: Impact on Primary Care. American Journal of Kidney Diseases 60:5, pages 707-709.
Crossref
Crossref
Gregory Reardon, Michael R. Wasserman, R. Scott McKenzie, R. Steve Hord, Brett Kilpatrick & Robert A. Bailey. (2012) The Prevalence and Recognition of Chronic Kidney Disease and Anemia in Long-Term Care Residents. The Consultant Pharmacist 27:9, pages 627-640.
Crossref
Crossref
Anne Marie Liles. (2012) Intravenous versus oral iron for treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease. American Journal of Health-System Pharmacy 69:14, pages 1206-1211.
Crossref
Crossref
Dagmara Hering, Felix Mahfoud, Antony S. Walton, Henry Krum, Gavin W. Lambert, Elisabeth A. Lambert, Paul A. Sobotka, Michael Böhm, Bodo Cremers, Murray D. Esler & Markus P. Schlaich. (2012) Renal Denervation in Moderate to Severe CKD. Journal of the American Society of Nephrology 23:7, pages 1250-1257.
Crossref
Crossref
Saurabh Somvanshi, Nahid Zia Khan & Mufazzal Ahmad. (2012) Anemia in chronic kidney disease patients. Clinical Queries: Nephrology 1:3, pages 198-204.
Crossref
Crossref
James Tollitt, Darren Green, Philip A Kalra & Hugh N McIntyre. (2012) Anaemia and the heart and kidneys. British Journal of Cardiac Nursing 7:6, pages 276-281.
Crossref
Crossref
Thaís Caroline Gurgel, Mariângela Leal Cherchiglia, Francisco de Assis Acurcio, Daniele Araújo Campos Szuster, Isabel Cristina Gomes & Eli Iola Gurgel Andrade. (2012) Utilização de eritropoetina por pacientes incidentes em hemodiálise no Sistema Único de Saúde, Brasil, 2002-2003. Cadernos de Saúde Pública 28:5, pages 856-868.
Crossref
Crossref
Lynn Thomas & Jennifer OthersenEmily McDonald. 2012. Nutrition Therapy for Chronic Kidney Disease. Nutrition Therapy for Chronic Kidney Disease
213
230
.
B. Terrier, M. Resche-Rigon, E. Andres, F. Bonnet, E. Hachulla, I. Marie, E. Rosenthal & P. Cacoub. (2012) Prevalence, characteristics and prognostic significance of anemia in daily practice. QJM: An International Journal of Medicine 105:4, pages 345-354.
Crossref
Crossref
Robert M. Shavelle, Ross MacKenzie & David R. Paculdo. (2012) Anemia and mortality in older persons: does the type of anemia affect survival?. International Journal of Hematology 95:3, pages 248-256.
Crossref
Crossref
Displaying 200 of 299 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list